NasdaqCM - Nasdaq Real Time Price USD
Acurx Pharmaceuticals, Inc. (ACXP)
0.3600
-0.0181
(-4.79%)
At close: May 9 at 4:00:02 PM EDT
0.3600
0.00
(0.00%)
After hours: May 9 at 5:05:37 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -0.14 | -0.29 | -0.85 | -1.04 |
| Low Estimate | -0.14 | -0.29 | -1.14 | -1.49 |
| High Estimate | -0.14 | -0.29 | -0.55 | -0.6 |
| Year Ago EPS | -0.28 | -0.26 | -0.87 | -0.85 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -- | -- | 4.5M | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 13.5M | -- |
| Year Ago Sales | -- | -- | -- | 4.5M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -100.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.24 | -0.28 | -0.23 | -0.18 |
| EPS Actual | -0.28 | -0.26 | -0.17 | -0.16 |
| Difference | -0.04 | 0.02 | 0.06 | 0.02 |
| Surprise % | -16.67% | 7.14% | 26.09% | 11.11% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.14 | -0.29 | -0.85 | -1.04 |
| 7 Days Ago | -0.38 | -0.5 | -2.06 | -2.87 |
| 30 Days Ago | -0.38 | -0.5 | -2.06 | -2.87 |
| 60 Days Ago | -0.38 | -0.5 | -2.06 | -2.87 |
| 90 Days Ago | -0.38 | -0.5 | -2.06 | -2.87 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ACXP | 50.00% | -11.54% | 2.87% | -23.67% |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/19/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/12/2024 |
Related Tickers
NGENF NervGen Pharma Corp.
2.5400
-1.17%
MDNAF Medicenna Therapeutics Corp.
0.7660
+9.43%
ACHV Achieve Life Sciences, Inc.
2.3500
-3.29%
ABOS Acumen Pharmaceuticals, Inc.
0.9801
-1.99%
ASBP Aspire Biopharma Holdings, Inc.
0.3565
+6.32%
OVID Ovid Therapeutics Inc.
0.2901
-1.33%
TSBX Turnstone Biologics Corp.
0.3399
+2.13%
SNSE Sensei Biotherapeutics, Inc.
0.3600
-4.41%
TNGX Tango Therapeutics, Inc.
1.1400
+3.64%
ATHA Athira Pharma, Inc.
0.2543
-4.61%